The U.S. Department of Health and Human Services has issued revised guidelines for pediatric antiretroviral treatment that state all HIV-positive infants, regardless of CD4-cell count or clinical symptoms, should receive anti-HIV drugs. Immediate treatment results in a 75% lower risk of death, according to a government study. Click on the link above for the full revised guidelines.
